FDA Recalls all Zantac Drugs
The U.S. Food and Drug Administration issued a recall for all Zantac (ranitidine) drugs including over the counter and prescription formulas on April 1, 2020. The administration stated the presence of an impurity N-nitrosodimethylamine (NDMA), which is a known cancer-causing agent, has been found in multiple independent laboratory tests. Over-the-counter Zantac and ranitidine-containing drugs had previously been recalled due to these same concerns.
Zantac Cancer Lawsuit Information
Exposure to NDMA can cause serious personal injury including liver damage, kidney damage, lung tumors, and fever. If you have taken Zantac over-the-counter products and have suffered a serious injury, contact us. You should consult your physician before stopping any medications. Our attorneys have represented thousands of people in class action and mass tort lawsuits who were injured by large corporations including those who make dangerous drugs and medical devices over the past 30 years and helped them get compensation for their injuries. We are proud to hold these large companies accountable. Many have been forced to pay back billions of dollars to the people they have injured.
